Fig. 2: Kaplan–Meier survival curves of efficacy-evaluable population.
PFS progression-free survival, OS overall survival, DSS disease-specific survival.
Fig. 2: Kaplan–Meier survival curves of efficacy-evaluable population. | Blood Cancer Journal
PFS progression-free survival, OS overall survival, DSS disease-specific survival.
